203 related articles for article (PubMed ID: 9555606)
1. Comments on article by Tran and associates, "Double-blind comparison of olanzapine versus risperidone in treatment of schizophrenia and other psychotic disorders".
Gheuens J; Grebb JA
J Clin Psychopharmacol; 1998 Apr; 18(2):176-9. PubMed ID: 9555606
[No Abstract] [Full Text] [Related]
2. Comments on "Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders" by Tran and Associates.
Kasper S; Küfferle B
J Clin Psychopharmacol; 1998 Aug; 18(4):353-6. PubMed ID: 9690709
[No Abstract] [Full Text] [Related]
3. Comments on article by Tran and colleagues, "Double-blind comparison of olanzapine versus risperidone in treatment of schizophrenia and other psychotic disorders".
Schooler NR
J Clin Psychopharmacol; 1998 Apr; 18(2):174-6. PubMed ID: 9555605
[No Abstract] [Full Text] [Related]
4. Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders.
Tran PV; Hamilton SH; Kuntz AJ; Potvin JH; Andersen SW; Beasley C; Tollefson GD
J Clin Psychopharmacol; 1997 Oct; 17(5):407-18. PubMed ID: 9315992
[TBL] [Abstract][Full Text] [Related]
5. Comparison of risperidone and olanzapine in the control of negative symptoms of chronic schizophrenia and related psychotic disorders in patients aged 50 to 65 years.
Feldman PD; Kaiser CJ; Kennedy JS; Sutton VK; Tran PV; Tollefson GD; Zhang F; Breier A
J Clin Psychiatry; 2003 Sep; 64(9):998-1004. PubMed ID: 14628974
[TBL] [Abstract][Full Text] [Related]
6. A randomized double-blind study of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorder.
Conley RR; Mahmoud R
Am J Psychiatry; 2001 May; 158(5):765-74. PubMed ID: 11329400
[TBL] [Abstract][Full Text] [Related]
7. Strategies for switching from conventional antipsychotic drugs or risperidone to olanzapine.
Kinon BJ; Basson BR; Gilmore JA; Malcolm S; Stauffer VL
J Clin Psychiatry; 2000 Nov; 61(11):833-40. PubMed ID: 11105736
[TBL] [Abstract][Full Text] [Related]
8. Quality of life and atypical antipsychotics.
Rudnick A
J Clin Psychopharmacol; 1998 Oct; 18(5):424-5. PubMed ID: 9790165
[No Abstract] [Full Text] [Related]
9. Comparative effectiveness of antipsychotic drugs.
Meibach RC
Am J Psychiatry; 2003 Mar; 160(3):589-90; author reply 592-3. PubMed ID: 12611851
[No Abstract] [Full Text] [Related]
10. Comparative effects of risperidone and olanzapine on cognition in elderly patients with schizophrenia or schizoaffective disorder.
Harvey PD; Napolitano JA; Mao L; Gharabawi G
Int J Geriatr Psychiatry; 2003 Sep; 18(9):820-9. PubMed ID: 12949850
[TBL] [Abstract][Full Text] [Related]
11. A pilot study of risperidone, olanzapine, and haloperidol in psychotic youth: a double-blind, randomized, 8-week trial.
Sikich L; Hamer RM; Bashford RA; Sheitman BB; Lieberman JA
Neuropsychopharmacology; 2004 Jan; 29(1):133-45. PubMed ID: 14583740
[TBL] [Abstract][Full Text] [Related]
12. Obsessive-compulsive symptoms during treatment with olanzapine and risperidone: a prospective study of 113 patients with recent-onset schizophrenia or related disorders.
de Haan L; Beuk N; Hoogenboom B; Dingemans P; Linszen D
J Clin Psychiatry; 2002 Feb; 63(2):104-7. PubMed ID: 11874209
[TBL] [Abstract][Full Text] [Related]
13. Return of menstruation after switching from risperidone to olanzapine.
Gazzola LR; Opler LA
J Clin Psychopharmacol; 1998 Dec; 18(6):486-7. PubMed ID: 9864085
[No Abstract] [Full Text] [Related]
14. Are the atypical antipsychotic drugs antidepressants?
Parker G; Malhi G
J Clin Psychopharmacol; 2002 Feb; 22(1):94-5. PubMed ID: 11799351
[No Abstract] [Full Text] [Related]
15. Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder.
Volavka J; Czobor P; Sheitman B; Lindenmayer JP; Citrome L; McEvoy JP; Cooper TB; Chakos M; Lieberman JA
Am J Psychiatry; 2002 Feb; 159(2):255-62. PubMed ID: 11823268
[TBL] [Abstract][Full Text] [Related]
16. Olanzapine and negative symptoms.
Rosen EH
J Clin Psychiatry; 1998 Oct; 59(10):537-8. PubMed ID: 9818636
[No Abstract] [Full Text] [Related]
17. Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder.
Bilder RM; Goldman RS; Volavka J; Czobor P; Hoptman M; Sheitman B; Lindenmayer JP; Citrome L; McEvoy J; Kunz M; Chakos M; Cooper TB; Horowitz TL; Lieberman JA
Am J Psychiatry; 2002 Jun; 159(6):1018-28. PubMed ID: 12042192
[TBL] [Abstract][Full Text] [Related]
18. Risperidone compared with olanzapine in a naturalistic clinical study: a cost analysis.
Taylor DM; Wright T; Libretto SE;
J Clin Psychiatry; 2003 May; 64(5):589-97. PubMed ID: 12755664
[TBL] [Abstract][Full Text] [Related]
19. One-year rehospitalization rates of patients discharged on atypical versus conventional antipsychotics.
Patel NC; Dorson PG; Edwards N; Mendelson S; Crismon ML
Psychiatr Serv; 2002 Jul; 53(7):891-3. PubMed ID: 12096177
[TBL] [Abstract][Full Text] [Related]
20. Hypothermia induced by risperidone and olanzapine in a patient with Prader-Willi syndrome.
Phan TG; Yu RY; Hersch MI
Med J Aust; 1998 Aug; 169(4):230-1. PubMed ID: 9734590
[No Abstract] [Full Text] [Related]
[Next] [New Search]
